Investor relations

We use the innovative power in combining material science and pharma,
revolutionizing drug delivery and giving patients a better and safer everyday life

We create new and innovative products with shorter time to market and mitigated risk.
We make this possible by combining material science & pharmaceutical development and by using established and approved active substances.

Financial Calendar

December 02 2021
Stora Aktiedagen

CEO Torbjörn W. Larsson presents the company on Aktiespararnas event Stora Aktiedagen in Stockholm.
Follow the presentation live online, via

February 22 2022
Year-end Report 2021

IR contact


Recieve press releases and reports via email.